Prevalent levels of RSV serum neutralizing antibodies in healthy adults outside the RSV-season

One of the main challenges in early clinical research with respiratory syncytial virus (RSV) live-attenuated vaccines (LAVs) is to assess immunogenicity in healthy adults. Healthy adults will have preexisting levels of serum neutralizing antibodies that could prematurely neutralize the LAV and under...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Der Plas, Johan L., Verdijk, Pauline, Van Brummelen, Emilie M. J., Jeeninga, Rienk E., Roestenberg, Meta, Burggraaf, Jacobus, Kamerling, Ingrid M.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482755/
https://www.ncbi.nlm.nih.gov/pubmed/31674870
http://dx.doi.org/10.1080/21645515.2019.1688040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482755/
https://www.ncbi.nlm.nih.gov/pubmed/31674870
http://dx.doi.org/10.1080/21645515.2019.1688040

Ejemplares similares